journal cover

A network-based approach to identify deregulated pathways and drug effects in metabolic syndrome

Nature Communications

Nov 20, 2019

Karla MisselbeckCorrado Priami

Abstract

Metabolic syndrome is a pathological condition characterized by obesity, hyperglycemia, hypertension, elevated levels of triglycerides and low levels of high-density lipoprotein cholesterol that increase cardiovascular disease risk and type 2 diabetes. Although numerous predisposing gen...read more

Mentioned in this Paper

Hyperglycemia
Hypertensive Disease
Molecular Pathway Deregulation
Validation
Larva
Macrophage
Biochemical Pathway
Metabolism
Obesity
Triglycerides
35
7
22
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Similar Papers Found In These Feeds

General Biology Journal eTOCs

Discover the latest general biology research in this collection of the top biology journals.

Type 2 Diabetes

This feed focuses on Type 2 Diabetes, a disease where the body doesn’t produce or respond to insulin anymore, leading to abnormal glucose levels in the blood.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Obesity & CV Disease

Obesity is becoming a major health concern and epidemic worldwide. It is regarded as a systemic, low-grade inflammatory state and has been linked to several diseases, one of major importance is cardiovascular diseases. Here is the latest research on obesity and cardiovascular diseases.

Drug & Digital Interventions

This feed describes how digital interventions, which are digital and mobile technologies used to support health system needs, can complement and improve pharmacotherapy in disease management. Discover the latest research on drug and digtial intervention here,

© 2020 Meta ULC. All rights reserved

A network-based approach to identify deregulated pathways and drug effects in metabolic syndrome

Nature Communications

Nov 20, 2019

Karla MisselbeckCorrado Priami

PMID: 31740673

DOI: 10.1038/s41467-019-13208-z

Abstract

Metabolic syndrome is a pathological condition characterized by obesity, hyperglycemia, hypertension, elevated levels of triglycerides and low levels of high-density lipoprotein cholesterol that increase cardiovascular disease risk and type 2 diabetes. Although numerous predisposing gen...read more

Mentioned in this Paper

Hyperglycemia
Hypertensive Disease
Molecular Pathway Deregulation
Validation
Larva
Macrophage
Biochemical Pathway
Metabolism
Obesity
Triglycerides
35
7
22

Related Papers

Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.
/papers/a-network-based-approach-to-identify-deregulated/31740673